A new study shows Americans are excited about the prospects of nanotechnology, but concerned about its potential health and environmental effects.
According to Andrew Maynard, chief science advisor for the Wilson Center's Project on Emerging Nanotechnologies, a project created in partnership with The Pew Charitable Trusts, the release of Approaches to Safe Nanotechnology: An Information Exchange with NIOSH and Strategic Plan for NIOSH Nanotechnology Research: Filling the Knowledge Gaps is a small but important step forward by the U.S. government to address the possible health implications of nanotechnology.
The Wilson Center's new Project on Emerging Nanotechnologies will study the potential health and environmental implications of nanotechnology products. Developments from this cutting-edge science will increasingly affect our everyday lives, from medicines to consumer products to new energy sources.
"It is not if it is going to happen. It is when, and where, and how bad," said Dr. Michael Osterholm at the first meeting sponsored by the Wilson Center's new Global Health Initiative. Video and powerpoint presentation available.
SEPTEMBER 2005--Inaugural Event to Examine Potential Avian Influenza Outbreak
A new study released by the Wilson Center's Project on Emerging Nanotechnologies, a project created in partnership with The Pew Charitable Trusts, reveals that while Americans welcome new potential life-saving and -enhancing applications promised by nanotechnology, they voice concern over its potential long-term human health and environmental effects and the ability of government and the private sectors to manage such risks.
In partnership with the Pew CharitableTrusts, the Wilson Center will work with industry, academia, NGOs, and others to explore the future of nanotechnologies and their implications for the environment and human health.
A discussion with Richard Sezibera, Ambassador of Rwanda to the United States, Kenneth Behring, businessman and private philanthropist and Christine Warnke, government affairs advisor for the law firm Hogan & Hartson.
David Rejeski, director of the Wilson Center's Foresight and Governance Project, lauds the benefits but warns of the ethical and moral implications of the sequencing of the human genome.
Do companies have the right to patent genetic discoveries? This has become one of the most controversal intellectual property issues of our time. A panel of experts debated the ethical, legal, and financial implications of gene patenting at a recent Wilson Center event.